The Conversation (0)
Spectral Announces Fourth Quarter and Fiscal 2017 Results
Mar. 29, 2018 09:13AM PST
Pharmaceutical InvestingSpectral Medical (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its financial results for the fourth quarter and for the year ended December 31, 2017. As quoted in the press release: Revenue for the three months ended December 31, 2017 was $918,000 compared …
Spectral Medical (TSX:EDT), a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its financial results for the fourth quarter and for the year ended December 31, 2017.
As quoted in the press release:
Revenue for the three months ended December 31, 2017 was $918,000 compared to $806,000 for the same three-month period last year. Revenue for the year ended December 31, 2017 was $3,806,000 compared to $3,545,000 for the prior year, representing an increase of $261,000, or 7%.
